Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Abstract: Benchmark datasets normally have relatively conserved relationships and low fraction of outliers, indicated from higher determination coefficient (R2) and ...